Pfizer develop healthcare hub for startups

Pfizer-Hub

Pharmaceutical corporation Pfizer has announced the launch a new initiative designed to help healthcare and technology start-ups grow.

The Pfizer Healthcare Hub: London will support start-ups who have developed a product or service that is ready for use by healthcare professionals and which shows evidence of benefits to patients or clinicians.

The initiative comes as various technology is beginning to play an increasing role in helping deliver and improve healthcare.

Pfizer hopes that by providing access to its network and resources, the hub will help late-stage start-ups reach more patients and providers such as the NHS faster.

Start-ups will compete for a share of a grant of £56k and a year-long programme of support, helping them to navigate the UK’s health system, and giving them the opportunity to meet the people who can move their ideas and their businesses forward.

Erik Nordkamp, Pfizer UK managing director said: “I’m delighted that we’ll be launching the Pfizer Healthcare Hub here in the UK.

“We live in a country that is already a centre for original thinking and innovation within healthcare and our goal is to accelerate the success of the brightest start-ups in this field and help them make a difference to patients.”

The Pfizer Healthcare Hub: London is the latest of Pfizer’s efforts to support healthcare companies. The corporation has existing centres in New York, Berlin and Tel Aviv and new hubs are being launched simultaneously in Stockholm, Sydney and Toronto.

Dr Hamish Graham, Pfizer Healthcare Hub: London Manager, said: “The Healthcare Hub will provide a platform for start-ups to harness Pfizer’s global network, enabling them to get access to our expertise, understanding and guidance. We hope, with our support, that they’ll be able to reach their goals and get their innovations adopted within the health service.”

 



'Pfizer develop healthcare hub for startups' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

© 2017 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.